MITO(Quitar la ciudad)
Stealth Bio·NASDAQ
--
--(--)
MITO fundamentals
During Q4 2021, Stealth Bio (MITO) reported revenue of 0, a YoY change of 0.00%. Net income was -20.14M, a YoY change of -9.80%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q4,2017 | Q4,2018 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | TTM |
|---|
Start Date | Oct 1, 2017 | Oct 1, 2018 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | -- |
End Date | Dec 31, 2017 | Dec 31, 2018 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 0 -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- |
Cost of Revenue | 0 -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- |
Operating Expenses | 20.57M -- | 20.98M +1.99% | 15.03M -- | 11.93M -- | 10.88M -- | 10.83M -- | 11.08M -26.28% | 11.00M -7.81% | 11.45M +5.18% | 12.78M +17.99% | 46.30M -- |
Selling, General and Administrative Expenses | 3.56M -- | 9.68M +171.59% | 5.18M -- | 4.52M -- | 4.67M -- | 4.99M -- | 4.98M -3.88% | 5.08M +12.38% | 4.71M +0.77% | 4.98M -0.28% | 19.75M -- |
Research and Development Expenses | 17.01M -- | 11.30M -33.54% | 9.85M -- | 7.41M -- | 6.21M -- | 5.84M -- | 6.10M -38.06% | 5.91M -20.15% | 6.74M +8.50% | 7.80M +33.60% | 26.56M -- |
Operating Income | -20.57M -- | -20.98M -1.99% | -15.03M -- | -11.93M -- | -10.88M -- | -10.83M -- | -11.08M +26.28% | -11.00M +7.81% | -11.45M -5.18% | -12.78M -17.99% | -46.30M -- |
Non-Operating Income (Loss) | -1.50M -- | -5.61M -274.06% | -513.00K -- | -441.00K -- | -328.00K -- | -7.50M -- | 3.39M +760.62% | -7.41M -1580.27% | 5.15M +1669.82% | -7.35M +2.03% | -6.22M -- |
Other Non-Operating Income (Loss) | 40.96K -- | 1.27M +3004.62% | -636.00K -- | 636.00K -- | -330.00K -- | -5.70M -- | 3.39M +632.70% | -6.92M -1188.52% | 5.15M +1660.30% | -6.11M -7.29% | -4.50M -- |
Net Interest Expense | 1.54M -- | 6.88M +346.67% | -123.00K -- | 1.08M -- | -2.00K -- | 1.81M -- | -1.00K +99.19% | 487.00K -54.78% | -- -- | 1.24M -31.36% | -- -- |
Interest Expense | 1.57M -- | 6.93M +341.42% | -- -- | 1.09M -- | -- -- | 1.81M -- | -- -- | 488.00K -55.27% | -- -- | 1.24M -31.31% | -- -- |
Interest Income | 30.61K -- | 54.22K +77.15% | 123.00K -- | 14.00K -- | 2.00K -- | 0 -- | 1.00K -99.19% | 1.00K -92.86% | -- -- | 1.00K -- | -- -- |
Pretax Income From Continuing Operations | -22.07M -- | -26.59M -20.48% | -15.54M -- | -12.37M -- | -11.21M -- | -18.34M -- | -7.69M +50.52% | -18.41M -48.81% | -6.30M +43.83% | -20.14M -9.80% | -52.53M -- |
Income Tax Expense | 0 -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- |
Net Income | -22.07M -- | -26.59M -20.48% | -15.54M -- | -12.37M -- | -11.21M -- | -18.34M -- | -7.69M +50.52% | -18.41M -48.81% | -6.30M +43.83% | -20.14M -9.80% | -52.53M -- |
Net Income Attributable to Owners of the Company | -22.07M -- | -26.59M -20.48% | -15.54M -- | -12.37M -- | -11.21M -- | -18.34M -- | -7.69M +50.52% | -18.41M -48.81% | -6.30M +43.83% | -20.14M -9.80% | -52.53M -- |
Net Income Attributable to Common Stockholders | -22.07M -- | -26.59M -20.48% | -15.54M -- | -12.37M -- | -11.21M -- | -18.34M -- | -7.69M +50.52% | -18.41M -48.81% | -6.30M +43.83% | -20.14M -9.80% | -52.53M -- |
Other Comprehensive Income | 0 -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- |
Total Comprehensive Income | 0 -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- |
Basic EPS | -- -- | -4.66 -- | -0.04 -- | -0.02 -- | -0.02 -- | -0.03 -- | -0.01 +75.00% | -0.03 -50.00% | -0.01 +50.00% | -0.03 -- | -0.08 -- |
Diluted EPS | -- -- | -- -- | -0.04 -- | -- -- | -0.02 -- | -- -- | -0.01 +75.00% | -- -- | -0.01 +50.00% | -- -- | -- -- |
You can ask Aime
No Data
